Toray Develops Porous Fiber to Adsorb Pathogens of Intractable Diseases
NQ Score
48/100
AI Summary (NQ-processed)
Toray has developed a technology to precisely control the pore size of PMMA porous fibers, enabling the selective removal of disease-causing substances. The technology aims to offer new blood purification therapies for intractable diseases.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the primary benefit of this new technology?
- A: It enables the selective adsorption and removal of large-molecular-weight disease-causing substances that were previously difficult to capture.